SAN FRANCISCO, CA, Strategikon Pharma announced the closing of Series A financing, led by Osage Venture Partners.
Strategikon Pharma announced the closing of Series A financing, led by Osage Venture Partners in partnership with Wing Venture Capital and Bascom Ventures.
Clinical Maestro, Strategikon's flagship product, is a cloud-based platform that modernizes outsourcing for clinical programs. It enables all participants in clinical trials, Sponsor Companies, Vendors and Service Providers, to plan studies, model and manage clinical contracts in an entirely systematic way.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about